{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:54:49Z","timestamp":1778936089600,"version":"3.51.4"},"reference-count":44,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can J Psychiatry"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>We examined the prevalence and correlates of prescription drug misuse (PDM) in a population-based sample of adults from Alberta.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data were collected from 3511 adults in Alberta aged 18 years and older in 2002 using a computer-aided telephone survey; the survey response rate was 57.4%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The prevalence of 12-month PDM in Alberta was 8.2% in 2002. Opiates were the most frequently misused drug class, followed by sedatives, stimulants, and tranquilizers. Current disability was particularly associated with PDM. Odds of PDM were also elevated among adult students and adults with a high school diploma relative to adults with a post-secondary degree. Past-year problem gambling, illicit drug use, and alcohol use and dependence were each associated with PDM, while past-year binge drinking and daily smoking were not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Findings suggest PDM was an important public health concern in Alberta in 2002. Estimates suggest prescription use and misuse have increased substantially in Canada since that time. There is an urgent need for an ongoing assessment of this evolving problem so that effective prevention and therapeutic strategies can be developed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/070674371105600106","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T20:59:18Z","timestamp":1484341158000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence and Correlates of 12-Month Prescription Drug Misuse in Alberta"],"prefix":"10.1177","volume":"56","author":[{"given":"Cheryl L","family":"Currie","sequence":"first","affiliation":[{"name":"Student, School of Public Health, University of Alberta, Edmonton, Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald P","family":"Schopflocher","sequence":"additional","affiliation":[{"name":"Associate Professor, School of Public Health and Faculty of Nursing, University of Alberta, Edmonton, Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T Cameron","family":"Wild","sequence":"additional","affiliation":[{"name":"Professor, School of Public Health, University of Alberta, Edmonton, Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,1,1]]},"reference":[{"key":"bibr1-070674371105600106","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418010-00004"},{"key":"bibr2-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.09.018"},{"key":"bibr3-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-0736(97)80022-2"},{"key":"bibr4-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0704(18)30042-3"},{"key":"bibr5-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(01)00433-8"},{"key":"bibr6-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.05.004"},{"key":"bibr7-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.019"},{"key":"bibr8-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.008"},{"key":"bibr9-070674371105600106","volume-title":"Report of the International Narcotics Control Board for 2008","author":"International Narcotics Control Board","year":"2009"},{"key":"bibr10-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00003-6"},{"key":"bibr11-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.009"},{"key":"bibr12-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2008.06.005"},{"key":"bibr13-070674371105600106","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0708"},{"key":"bibr14-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.03.006"},{"key":"bibr15-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1007\/BF03405469"},{"key":"bibr16-070674371105600106","volume-title":"Canadian Alcohol and Drug Use Monitoring Survey: Summary of results for 2008","author":"Health Canada","year":"2009"},{"key":"bibr17-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.47"},{"key":"bibr18-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(94)90036-1"},{"key":"bibr19-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02024.x"},{"key":"bibr20-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11470-X"},{"key":"bibr21-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01539.x"},{"key":"bibr22-070674371105600106","volume-title":"The Canadian Problem Gambling Index: Final report","author":"Ferris J","year":"2001"},{"key":"bibr23-070674371105600106","volume-title":"Essentials of epidemiology in public health","author":"Aschengrau A","year":"2008"},{"key":"bibr24-070674371105600106","volume-title":"Essential epidemiology: Principles and applications","author":"Oleckno WA","year":"2002"},{"key":"bibr25-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1742-3"},{"key":"bibr26-070674371105600106","volume-title":"Prescription drugs: Abuse and addiction","author":"National Institute of Drug Abuse","year":"2005"},{"key":"bibr27-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181b99f35"},{"key":"bibr28-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1080\/1360786031000150739"},{"key":"bibr29-070674371105600106","volume-title":"The misuse of prescription drugs by post-secondary students","author":"Cohen IM","year":"2008"},{"issue":"2","key":"bibr30-070674371105600106","first-page":"19","author":"Johnston L","year":"2004","journal-title":"NIH Publication 04\u20135508"},{"key":"bibr31-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.10.1501"},{"key":"bibr32-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.07.005"},{"key":"bibr33-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.08.024"},{"key":"bibr34-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.01.007"},{"key":"bibr35-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02056.x"},{"key":"bibr36-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.07.016"},{"key":"bibr37-070674371105600106","volume-title":"Avoiding opioid abuse while managing pain: A guide for practitioners","author":"Webster LR","year":"2007"},{"key":"bibr38-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2005.00072.x"},{"key":"bibr39-070674371105600106","volume-title":"Goodman & Gilman's, the pharmacological basis of therapeutics","author":"Brunton L","year":"2006","edition":"11"},{"key":"bibr40-070674371105600106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.06.010"},{"key":"bibr41-070674371105600106","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.94.2.266"},{"key":"bibr42-070674371105600106","volume-title":"Narcotic drugs: Estimated world requirements for 2004\u2014statistics for 2002","author":"International Narcotics Control Board","year":"2004"},{"key":"bibr43-070674371105600106","volume-title":"Narcotic drugs: Estimated world requirements for 2009\u2014statistics for 2007","author":"International Narcotics Control Board","year":"2008"},{"issue":"2","key":"bibr44-070674371105600106","first-page":"104","volume":"100","author":"Popova S","year":"2009","journal-title":"How many people in Canada use prescription opioids non-medically in general and street drug-using populations? Can J Public Health"}],"container-title":["The Canadian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674371105600106","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674371105600106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:12:55Z","timestamp":1777392775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/070674371105600106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1177\/070674371105600106"],"URL":"https:\/\/doi.org\/10.1177\/070674371105600106","relation":{},"ISSN":["0706-7437","1497-0015"],"issn-type":[{"value":"0706-7437","type":"print"},{"value":"1497-0015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}